On November 28, Moscow hosted the conference “IT in healthcare 2019”, which brought together various healthcare industry players. The main idea behind the conference is to create a single digital healthcare channel through the integration of IT systems developed by healthcare providers and federal IT systems.
You certainly know very well that a drug labelling project is currently in full swing as we try to keep you up to date on latest developments in the industry. This year was marked by a lot of meetings, round table discussions, talks that were held at different levels: both at the level of regulatory agencies and major players in the labelling market.
And this time we also couldn’t overlook the specific topic discussed by the medical community and readily accepted the invitation to demonstrate our labelling implementation project at the conference, particularly with regard to the fact that the conference was attended by nearly all members of the supply chain.
Alexey emphasized that perhaps the most important link in the project implementation process in NANOLEK is a cross-functional team, with a core made up of approx. 7 people. They covered the necessary business segments, such as packaging processes, serialization equipment, qualification and validation, etc. On the whole, the project team consisted of 35 people who got involved as needed.”
“Late last week, we labelled 2550 packages as part of two commercial batches of the drug intended to treat mucopolysaccharidosis type II. We have faced of course various challenges during the work and though we haven’t managed to solve all of them so far, solving is already in progress.
We used a few simple but effective rules in terms of management and thus, in empirical way, achieved the results that we have today.
Generally speaking, I can give an unequivocal answer to the question “How do we benefit from labelling as manufacturer?”: We stay protected against counterfeiting and re-launch of drugs to market.”
Well, our discussion is over, however there are still many productive and mutually beneficial meetings that await us in the future.